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Aso and colleagues concluded that a nationwide study
showed ‘high mortality rates’ in patients who received
venoarterial extracorporeal membrane oxygenation
(VA-ECMO), particularly in those with cardiogenic shock
and cardiac arrest [1]. They stated that in-hospital mortal-
ity in these patients was 77.1 %. We believe that some
comparisons should be made to determine whether the
mortality rate is really that high.
ECMO, especially percutaneous cardiopulmonary sup-
port (PCPS), has been used extensively in emergency medi-
cine and surgery as a simple but powerful device since
1987 in Japan [2]. Emergency cardiopulmonary support has
been used in a variety of emergency cases and improved
resuscitation. Maekawa et al. reported that, in a propensity-
matched study of 162 out-of-hospital cardiac arrest pa-
tients, neurologic outcome in the extracorporeal cardiopul-
monary resuscitation (CPR) group was improved compared
with that in the conventional CPR group. In this study,
CPR duration averaged 49 min, the ICU survival rate was
95.8 %, and the cerebral performance category status 1 or 2
at 3 months was 29.2 % [3]. This device has a beneficial
effect on out-of-hospital cardiac arrest patients.
In the in-hospital cardiac arrest setting, Chen et al. re-
ported that, in a propensity analysis of 113 cardiac arrest
patients, extracorporeal CPR resulted in a higher survival
rate to discharge than conventional CPR (28.8 % versus
12.3 %) [4]. Shin et al. reported that, in a propensity score
matching analysis of 90 patients with cardiogenic cardiac
arrest, in-hospital survival was higher with extracorporeal
CPR (35.5 % versus 8.8 %) [5]. These reports suggested that
in-hospital cardiac arrest ‘survival rates’ are around
10–20 % even in the hospital where extracorporeal CPR
could be used. In the Aso et al. report [1], the ‘mortality’ of
cardiac arrest patients in cardiogenic shock was 77.1 %.
This percentage also included out-of-hospital cardiac
arrests, so the in-hospital cardiac arrest mortality could be
lower. Furthermore, physicians mostly use ECMO as a last-
ditch measure because this procedure may have lethal
adverse vascular effects and is very expensive. Even in such
a critical situation, about one quarter of the patients
survived to discharge in this nationwide database. From the
viewpoint of physicians, this mortality rate does not appear
high. These results could suggest that VA-ECMO may be a
potential therapy for in-hospital cardiac arrest patients.
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We thank Dr. Shimizu and Dr. Ogura for their insightful
comments. As they pointed out, the eligible patients in our
study included out-of-hospital and in-hospital cardiac arrest
patients, and the reported mortality rate (77.1 %) may be
higher than that for in-hospital cardiac arrest patients
alone. We agree that physicians mostly use VA-ECMO as a
last-ditch measure. The aim of the present study was to
clarify the current status of cardiac arrest patients treated
with VA-ECMO using a national inpatient database. A
previous review reported that the in-hospital mortality rate
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of cardiogenic shock patients with cardiac arrest varied
widely, ranging from 6 % to 59 %, because of differences in
population selection [6]. The previous studies cited by Dr.
Shimizu and Dr. Ogura are limited because of their small
sample sizes from single centers [3–5]. Our data were
based on a national database that covers approximately
92 % of all tertiary-care emergency hospitals in Japan.
Therefore, our results are more reliable than those in the
previous studies.
We agree with Dr. Shimizu and Dr. Ogura that VA-
ECMO may be a potential therapy for in-hospital cardiac
arrest patients. However, the present study did not provide
any evidence on the effectiveness of VA-ECMO because
of the lack of a control group.
Dr. Shimizu and Dr. Ogura commented that “from the
viewpoint of physicians, this mortality rate does not
appear high.” However, we do not believe that this rate is
low. The discrepancy may simply depend on differences in
our senses of values. We believe that the important point
is to acknowledge that there is much room for improve-
ment in this rate, and again we would like to emphasize
that further studies are needed to investigate the effects of
VA-ECMO.
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